The record
IARC Volume 136 lists talc with limited evidence for cancer in humans, sufficient evidence for cancer in experimental animals, strong mechanistic evidence, and an overall Group 2A evaluation.
Claim scope
IARC hazard classification and its stated evidence streams only.
What this source does not establish
This record does not quantify risk at a particular dose or exposure scenario, establish individual causation, identify a particular product or batch as contaminated, or collapse talc into the separately evaluated asbestos agent.
Source
Official Scientific Evaluation — Summary of final evaluations, printed p. 805